← Eichor
Study identifier: NCT06884098 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

A Study to Compare PK Characteristics and Safety Profiles Between AD-228B and AD-2284

Condition: Primary Hypercholesterolaemia  ·  Sponsor: Addpharma Inc.

PhasePhase 1
Planned participants60
Who can joinAll sexes, 19 Years to no upper limit
Healthy volunteersYes

About this study

Primary endpoint of this study is to evaluate the pharmacokinetic characteristics of AD-228B in healthy subjects.

This description comes directly from the study's public registry record.

Talk to the study team

JeongEun Park  ·  +82-31-891-6989  ·  parkje@addpharma.co.kr

Always discuss trial participation with your own doctor first.

Locations (1)

H Plus Yangji HospitalSeoul, South KoreaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06884098